Great Valley Advisor Group, Inc. Astrazeneca PLC Transaction History

Great Valley Advisor Group, Inc.

$4.08 Billion
Q2 2025

A detailed history of Great Valley Advisor Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 4,949 shares of AZN stock, worth $414,874. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,949

Previous 3,992 23.97%

Holding current value

$414,874

Previous $293,000 17.75%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $62,080 - $71,775	957 Added 23.97%	4,949 $345,000
Q1 2025 May 08, 2025	SELL	$65.37 - $77.96 $5,294 - $6,314	-81 Reduced 1.99%	3,992 $293,000
Q4 2024 Feb 24, 2025	SELL	$63.2 - $79.58 $3,412 - $4,297	-54 Reduced 1.31%	4,073 $266,000
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $13,110 - $14,983	-171 Reduced 3.98%	4,127 $321,000
Q2 2024 Jul 16, 2024	SELL	$66.81 - $80.83 $19,241 - $23,279	-288 Reduced 6.28%	4,298 $335,000
Q1 2024 May 03, 2024	BUY	$61.03 - $69.57 $45,711 - $52,107	749 Added 19.52%	4,586 $310,000
Q4 2023 Feb 05, 2024	SELL	$61.89 - $69.28 $29,335 - $32,838	-474 Reduced 11.0%	3,837 $258,000
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $54,149 - $59,869	835 Added 24.02%	4,311 $291,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $5,173 - $5,609	74 Added 2.18%	3,476 $248,000
Q1 2023 May 02, 2023	SELL	$63.15 - $71.6 $32,522 - $36,874	-515 Reduced 13.15%	3,402 $236,000
Q4 2022 Jan 31, 2023	BUY	$54.21 - $70.44 $212,340 - $275,913	3,917 New	3,917 $265,000
Q2 2022 Jul 19, 2022	BUY	$59.26 - $71.14 $192,417 - $230,991	3,247 New	3,247 $215,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $230,557 - $272,426	-4,268 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$55.56 - $60.79 $93,285 - $102,066	-1,679 Reduced 28.23%	4,268 $256,000
Q2 2021 Jul 27, 2021	BUY	$48.42 - $60.18 $2,178 - $2,708	45 Added 0.76%	5,947 $339,000
Q1 2021 Apr 20, 2021	SELL	$47.16 - $54.44 $1.1 Million - $1.27 Million	-23,361 Reduced 79.83%	5,902 $293,000
Q4 2020 Jan 29, 2021	BUY	$48.52 - $58.02 $48,374 - $57,845	997 Added 3.53%	29,263 $1.46 Million
Q3 2020 Oct 21, 2020	BUY	$53.07 - $61.1 $1.5 Million - $1.73 Million	28,266 New	28,266 $1.55 Million

Others Institutions Holding AZN

# of Institutions

1,422

Shares Held

498M

Call Options Held

7.11M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $260B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Astrazeneca PLC Transaction History